Segment Reporting - Additional Information (Detail) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) Segment	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Number of operating segments | Segment	1
Accounts receivable, percentage by customer	100.00%	100.00%
Revenue	$ 182,660	$ 206,400	$ 206,400
Customer Concentration Risk | Pfizer [Member]
Revenue	$ 20,100	$ 21,100
Customer Concentration Risk | Sales Revenue | Pfizer [Member]
Accounts receivable, percentage by customer	11.00%	10.20%
Customer Concentration Risk | Accounts Receivable [Member] | Pfizer [Member]
Accounts receivable, percentage by customer	14.70%
Customer Concentration Risk | Accounts Receivable [Member] | Purolite [Member]
Accounts receivable, percentage by customer			12.70%
Customer Concentration Risk | Total Trade Accounts Receivable Royalties And Other Receivables | Pfizer [Member]
Accounts receivable, percentage by customer	10.00%
Customer Concentration Risk | Total Trade Accounts Receivable Royalties And Other Receivables | Purolite [Member]
Accounts receivable, percentage by customer			10.00%